Cargando…

The Clinical Utility of D-Dimer and Prothrombin Fragment (F1+2) for Peripheral Artery Disease: A Prospective Study

D-dimer and prothrombin fragment (F1+2) levels are elevated in patients with peripheral artery disease (PAD). We examined their prognostic potential in predicting decreasing ABI and major adverse limb events (MALE). A total of 206 patients were recruited from St. Michael’s Hospital and followed for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arfan, Sara, Zamzam, Abdelrahman, Syed, Muzammil H., Jain, Shubha, Jahanpour, Niousha, Abdin, Rawand, Qadura, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028031/ https://www.ncbi.nlm.nih.gov/pubmed/35453628 http://dx.doi.org/10.3390/biomedicines10040878

Ejemplares similares

Urinary Cystatin C Has Prognostic Value in Peripheral Artery Disease
por: Li, Ben, et al.
Publicado: (2022)

Urinary Fatty Acid Binding Protein 3 Has Prognostic Value in Peripheral Artery Disease
por: Li, Ben, et al.
Publicado: (2022)

The prognostic capability of inflammatory proteins in predicting peripheral artery disease related adverse events
por: Li, Ben, et al.
Publicado: (2022)

Angiogenesis-related proteins as biomarkers for peripheral artery disease
por: Li, Ben, et al.
Publicado: (2023)

Urinary neutrophil gelatinase-associated lipocalin (NGAL) can potentially predict vascular complications and reliably risk stratify patients with peripheral arterial disease
por: Ehsan, Mehroz, et al.
Publicado: (2022)

Plasma complement component C2: a potential biomarker for predicting abdominal aortic aneurysm related complications
por: Feridooni, Tiam, et al.
Publicado: (2022)

Serum Metabolic Signatures of Chronic Limb-Threatening Ischemia in Patients with Peripheral Artery Disease
por: Azab, Sandi M., et al.
Publicado: (2020)

Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease
por: Zamzam, Abdelrahman, et al.
Publicado: (2021)

MicroRNA Profile of Patients with Chronic Limb-Threatening Ischemia
por: Syed, Muzammil H., et al.
Publicado: (2020)

Fatty Acid Binding Protein 4—A Circulating Protein Associated with Peripheral Arterial Disease in Diabetic Patients
por: Zamzam, Abdelrahman, et al.
Publicado: (2020)

Fatty acid binding protein 3 is associated with peripheral arterial disease
por: Syed, Muzammil H., et al.
Publicado: (2020)

Validating fatty acid binding protein 3 as a diagnostic and prognostic biomarker for peripheral arterial disease: A three-year prospective follow-up study
por: Zamzam, Abdelrahman, et al.
Publicado: (2022)

Plateletworks(®) as a Point-of-Care Test for ASA Non-Sensitivity
por: Khan, Hamzah, et al.
Publicado: (2021)

Perceived Challenges to Routine Uptake of the Ankle Brachial Index within Primary Care Practice
por: Chiu, Lily Y. C., et al.
Publicado: (2021)

Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease
por: Alsuwailem, Bader, et al.
Publicado: (2021)

Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
por: Khan, Hamzah, et al.
Publicado: (2022)

Increasing Awareness for Peripheral Artery Disease through the Identification of Novel Biomarkers
por: Li, Ben, et al.
Publicado: (2023)

Prothrombin fragment F1+2 in patients with antiphospholipid antibodies
por: Ambrozic, A, et al.
Publicado: (2004)

Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry
por: Khan, Hamzah, et al.
Publicado: (2020)

A Systematic Review of Interleukins as Diagnostic and Prognostic Biomarkers for Peripheral Artery Disease
por: Djahanpour, Niousha, et al.
Publicado: (2023)

Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)
por: Khan, Hamzah, et al.
Publicado: (2021)

Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
por: Khan, Hamzah, et al.
Publicado: (2020)

Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA
por: Yang, Yong, et al.
Publicado: (2022)

Structural transitions during prothrombin activation: On the importance of fragment 2
por: Adams, Ty E., et al.
Publicado: (2016)

Evaluation of the Prothrombin Fragment 1.2 in Patients with COVID-19
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Valproic Acid Induces Endothelial-to-Mesenchymal Transition-Like Phenotypic Switching
por: Murugavel, Shamini, et al.
Publicado: (2018)

Current Biomarkers for Carotid Artery Stenosis: A Comprehensive Review of the Literature
por: Khan, Hamzah, et al.
Publicado: (2023)

D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis
por: Long, Hui, et al.
Publicado: (2020)

Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy
por: Khan, Hamzah, et al.
Publicado: (2022)

Management of a Mycotic Aneurysm in a Patient with COVID-19: A Case Report
por: Syed, Muzammil H., et al.
Publicado: (2021)

Identification and characterization of a factor Va-binding site on human prothrombin fragment 2
por: Friedmann, Alexander P., et al.
Publicado: (2019)

The Role of Fatty Acid Binding Protein 3 in Cardiovascular Diseases
por: Li, Ben, et al.
Publicado: (2022)

A case of congenital prothrombin deficiency with two concurrent mutations in the prothrombin gene
por: Mansory, Eman M., et al.
Publicado: (2021)

Diagnostic performances of D-dimer, prothrombin time, and red blood cell distribution width for coronary artery lesion in children with acute stage Kawasaki disease
por: Yin, Qi-Gai, et al.
Publicado: (2023)

Soluble P-selectin and correlation with Prothrombin Fragment 1 + 2 in myeloid malignancies in Cipto Mangunkusumo general hospital
por: Sukrisman, Lugyanti
Publicado: (2021)

Clinical utility of decarboxylation prothrombin combined with α-fetoprotein for diagnosing primary hepatocellular carcinoma
por: Fu, Jun, et al.
Publicado: (2018)

The progress of prothrombin time measurement
por: Horsti, Juha
Publicado: (2009)

Prothrombin Time in Normal Indians
por: Braganca, Beatriz M., et al.
Publicado: (1946)

A novel Canadian multidisciplinary acute care pathway for people hospitalised with a diabetic foot ulcer
por: Zamzam, Abdelrahman, et al.
Publicado: (2023)

Clinical utilization of four-factor prothrombin complex concentrate: a retrospective single center study
por: Naeem, Zaina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vpg9kurasq7tc8dlifk30rlqg2